One of the most promising areas in the therapeutics for metabolic diseases centers around activation of the pathways of energy expenditure. Brown adipose tissue is a particularly appealing target for increasing energy expenditure, given its amazing capacity to transform chemical energy into heat. In addition to classical brown adipose tissue, the last few years have seen great advances in our understanding of inducible thermogenic adipose tissue, also referred to as beige fat. A deeper understanding of the molecular processes involved in the development and function of these cell types may lead to new therapeutics for obesity, diabetes, and other metabolic diseases.
One of the most promising areas in the therapeutics for metabolic diseases centers around activation of the pathways of energy expenditure. Brown adipose tissue is a particularly appealing target for increasing energy expenditure, given its amazing capacity to transform chemical energy into heat. In addition to classical brown adipose tissue, the last few years have seen great advances in our understanding of inducible thermogenic adipose tissue, also referred to as beige fat. A deeper understanding of the molecular processes involved in the development and function of these cell types may lead to new therapeutics for obesity, diabetes, and other metabolic diseases.
The epidemic of obesity and type 2 diabetes presents a serious challenge to scientific and biomedical communities worldwide. While this epidemic was first obvious in the United States and other highly developed countries of Europe, it has spread across Asia, Africa, and Oceania. The purpose of this review is not to review all of the causes of these problems; clearly, increased access to foods high in caloric density and decreased physical movement have played important roles (Doria et al. 2008; Guilherme et al. 2008; Saltiel 2012) .
The most important single idea in the field of metabolic disease is the concept of energy balance. This means that, with the rare exception of malabsorption of nutrients, an animal cannot gain or lose weight unless there is an imbalance between food intake and energy expenditure. When energy intake chronically exceeds energy expenditure, weight gain and obesity result. This excess weight is stored in adipose tissue, which consists of fat cells, or adipocytes, which have an incredible capacity for storing surplus energy in the form of lipid. This tissue is not just a passive storage depot, but also an endocrine organ, secreting molecules like leptin that can regulate appetite and whole-body metabolism. In addition to these well-described energy-storing fat cells, adipocytes also exist that are highly effective at transforming chemical energy into heat. Brown adipocytes, which get their name from their high number of iron-containing mitochondria, are specialized to dissipate energy in the form of heat, a process called nonshivering thermogenesis. The thermogenic gene program of classical brown and beige fat cells (those brown cells that can emerge in white fat depots under certain conditions) can increase whole-body energy expenditure and therefore can protect against obesity and diabetes. This role of brown (and now beige) adipose cells in increasing whole-body metabolic rates has driven much of the interest in these cell types.
This review describes recent advances in our understanding of the development and function of both classical brown and beige fat cells. There has been an explosion of data identifying new pathways that activate these thermogenic cells; which avenues might prove useful in humans underlies the interest of our group and many others in this area. The final section of this review speculates on future prospects for brown and beige fat-based therapies in humans.
Brown adipose tissue (BAT)
Brown adipose was first described in small mammals and infants as an adaptation to defend against the cold. It was originally referred to as the hibernating organ due to its function in maintaining body temperature in hibernating animals (Hatai 1902; Rasmussen 1923; Cannon and Nedergaard 2004) .
Uncoupling protein 1 (UCP1) and thermogenesis
Classical BAT is typically located in the interscapular region and is most easily detected in infants and small mammals. It is referred to as ''classical'' in distinction from the inducible or beige adipocyte, which has unique molecular and developmental characteristics (discussed below in this review; see also Table 1 ). Both types of thermogenic adipocytes can increase energy expenditure through the uncoupling of oxidative metabolism from ATP production. This is a key function of UCP1. This long chain fatty acid-activated protein, highly selective for brown and beige adipose cells, sits in the inner membrane of mitochondria and catalyzes a proton leak across the inner membrane, dissipating the electrochemical gradient that has been generated via the electron transport [Keywords: brown fat; beige fat; obesity; adaptive thermogenesis; UCP1]chain (ETC) (Krauss et al. 2005; Bartelt et al. 2011; Fedorenko et al. 2012) . In most cells lacking UCP1, this proton gradient can only be dissipated through the formation of ATP through complex V (ATP synthase) in the ETC. When ATP is abundant in most cells, electrons can no longer easily enter the ETC, and fuel oxidation in the mitochondria is halted. The ''short circuit'' in the proton gradient caused by UCP1 means that fuel oxidation can be accelerated and is not limited by saturating concentrations of ATP. Hence, all of the biochemical steps of mitochondrial fuel oxidation (Krebs cycle and ETC) are accelerated, and the inherent inefficiencies in their reactions result in heat production.
Thermogenesis is facilitated by multilocular lipid stores (meaning many lipid droplets) and the extremely high mitochondrial content of brown adipocytes. It is also promoted by the extensive vascular and nerve supply to this tissue. Catecholamines released by sympathetic nerve terminals act on b-adrenergic receptors to stimulate BAT thermogenesis. Recently, it has also been suggested that catecholamines secreted by a certain subtype of macrophages can activate brown and beige fat in mice (Nguyen et al. 2011) . Sympathetic signaling is increased in the cold, and chronic cold exposure results in the activation and expansion of BAT (Klingenspor 2003) . Moreover, in the absence of b-adrenergic signaling, mice are unable to maintain their core temperature (Bachman et al. 2002) . Constitutive b-adrenergic agonism can have the same effect on BAT. This can be seen in pathological states with catecholamine-secreting tumors or induced pharmacologically with b-adrenergic agonists. BAT activity is also regulated by endocrine inputs from thyroid hormone, among others (Bianco 2011) .
Anti-obesity effects of brown fat-mediated adaptive thermogenesis
While brown fat was first noted for its ability to protect animals from hypothermia (Smith and Horwitz 1969) , the last 20 years have seen the anti-obesity/diabetes role of brown fat become clear. Earlier physiological studies had shown that caloric excess itself can stimulate brown adipose expansion and thermogenesis as an adaptation to maintain body weight. This process, known as dietinduced thermogenesis, is mediated by BAT and UCP1 (Rothwell and Stock 1997) . In the absence of UCP1, mice are prone to dietary obesity. Genetic ablation of brown fat with a UCP1 promoter-driven toxigene (Lowell et al. 1993) first illustrated the protection these tissues afforded against obesity and diabetes. It is important to note that these protective effects were observed in mice raised at ambient temperatures and did not require exposure to either cold or thermoneutral temperature to elicit the differences between control and mutant animals. Ablation of UCP1 with standard knockout technology generated mice that were very susceptible to hypothermia but had no propensity to develop obesity or diabetes when raised at ambient temperatures (Enerback et al. 1997) . Later work illustrated that this was because the UCP1 knockout mice shiver extensively, and most of the systemic effects of the ablation on energy metabolism were overwhelmed by the sustained shivering. When the UCP1 knockout mice were raised under thermoneutral conditions, they gained more weight and fat than their control littermates (Feldmann et al. 2009 ). This confounding effect of shivering was presumably not seen in the earlier brown fat ablations because the loss of UCP1 and UCP1-positive cells was not as complete with the toxigene, compared with that in the UCP1 knockout mice.
Since uncoupled thermogenesis is driven by oxidative metabolism, BAT is highly active metabolically. Its preferred fuel source is lipid, but it also actively takes up glucose, which is presumably the reason it is detectable by fluoro-deoxy-glucose (FDG)-positron emission tomography (PET) imaging. By relying on these fuel stores, activation of BAT has anti-obesity as well as glucoseand lipid-lowering effects, a property that might be exploited for therapeutic benefits (Bartelt et al. 2011) .
Transcriptional control of brown fat development and function
Despite having such a different physiological role from white adipose, brown adipocytes share many core molecular components with white fat cells. They both require the transcription factor PPARg for their development and function. Interestingly, however, mice with a dominantnegative mutation of PPARg (P465L) have defects in BAT but not white adipose tissue (WAT) function (Gray et al. 2006) . Members of the C/EBP transcription factor family (C/EBPa, C/EBPb, and C/EBPd) are involved in both white and brown adipogenesis. Overexpression of C/EBPb in certain white adipocytes induces the expression of brown fat cell genes, although its role in both brown and white adipogenesis suggests that it does not specifically regulate cell fate (Karamanlidis et al. 2007 ).
The molecular basis for the unique program in brown adipose remained unknown until the identification of Tables 2 and 3. PGC-1, a cold-induced PPARg-binding partner (Puigserver et al. 1998) . PGC-1 (now PGC-1a) expression is activated by the PKA-CREB pathway, which is downstream from the b-adrenergic receptor (Herzig et al. 2001 ). The PGC-1 family is now known to exist in three isoforms: PGC-1a, PGC-1b, and PRC. Furthermore, there are multiple splice variants of each, and the specific functions of these are still being elucidated (Ruas et al. 2012) . PGC-1a is expressed most highly in the kidney, liver, and muscle, tissues high in oxidative metabolism. This makes sense physiologically, as PGC-1a is a dominant regulator of mitochondrial biogenesis and oxidative metabolism (Lin et al. 2005) . PGC-1a regulates thermogenesis by inducing the expression of UCP1 and key enzymes of the mitochondrial respiratory chain. Ectopic expression of PGC-1a in white adipocytes robustly induces this gene program (Puigserver et al. 1998; Tiraby et al. 2003) . Mice with a whole-body deletion of PGC-1a have impaired cold-induced thermogenesis yet are surprisingly lean and resistant to dietary obesity due to centrally mediated hyperactivity (Lin et al. 2004) . A cell-autonomous role for PGC-1a in brown adipocytes was demonstrated by the generation of immortalized PGC-1a-null brown fat cell lines. This study demonstrated that PGC-1 is required for basal and cAMP-induced mitochondrial biogenesis and thermogenesis. However, PGC-1a-null brown adipocytes differentiate normally without alteration in numerous brown fatselective genes, indicating that it is not a determinant of brown adipocyte identity per se (Uldry et al. 2006) . While many factors besides the PGC-1s have been identified as regulators of brown fat development and function (see more discussion in ''Multiple Genetic Models Have Shown Modified Adaptive Thermogenesis Capacity in Brown/Beige Fat'' below), none had been shown to specifically confer brown fat cell identity until 2007. In an effort to identify such a factor, the expression level of all known and predicted transcriptional components in the mouse genome was surveyed . PRDM16 was one of three factors enriched in classical brown fat relative to WAT. PRDM16 was shown to be sufficient and necessary for the brown fat phenotype in cell culture models and sufficient to promote browning in visceral fat under b-adrenergic stimulation ). PRDM16 was originally described as being located at a chromosomal breakpoint in acute myeloid leukemia (Mochizuki et al. 2000; Nishikata et al. 2003) . It contains an N-terminal proline-rich domain, N-terminal and C-terminal zinc finger domains, and a SET domain, a domain often associated with histone lysine methyltransferase activity. A shorter form of PRDM16 has been detected in adult T-cell leukemia cells and in Northern blots from a number of mouse tissues (Yoshida et al. 2004; Seale et al. 2007 ). Whether these shorter forms are functionally relevant in brown adipose biology remains unknown.
When ectopically expressed in mesenchymal fibroblasts with no specific brown or white fat characteristics, PRDM16 induced the full molecular program of brown adipose cells ). Specifically, PRDM16 induced the expression of thermogenic genes, mitochondrial components, and other brown fat identity genes; PRDM16 also repressed the expression of several white fat-specific genes. Examination of these cells showed increased mitochondrial content as well as enhanced uncoupled respiration, consistent with the formation of fully functional brown adipose. Furthermore, introduction of PRDM16 into PPARg-expressing fibroblasts permitted the generation of ectopic brown fat, which could be transplanted in vivo .
Interestingly, mutation in the DNA-binding domain of PRDM16 did not impair its ability to induce the brown fat phenotype, suggesting that it acts as a transcriptional coregulator in this context. Further studies showed that PRDM16 binds and coactivates PGC-1a, PGC-1b, and PPARg Seale et al. 2008) . To better understand how PRDM16 specifically directs a brown fat gene program while repressing white fat genes, the PRDM16 protein complex was purified from fat cells. This complex was found to contain the proteins CtBP-1 and CtBP-2, which can repress gene expression. On the other hand, recruitment of PGC-1a and PGC-1b to PRDM16 displaces the CtBPs and permits coactivation of the brown fat program .
'Browning' of the white adipose depots and beige adipocytes
The 'browning' of WATs
The major white and brown adipose depots are located in anatomically different regions in both rodents and humans. However, it was reported almost 30 years ago that some multilocular, UCP1-positive fat cells exist within certain WATs in mice, rats, and cats. Furthermore, these cells became more prominent upon prolonged stimulation by cold (Young et al. 1984; Loncar et al. 1986 Loncar et al. , 1988a . Similar phenomena were later observed in rodents treated with b3-adrenergic receptor agonists that elevate intracellular cyclic AMP, like CL316, 243 (Cousin et al. 1992) .
Interestingly, it has been reported that distinct genetic loci control the number of UCP1-positive cells in the white and classical brown fat depots in rodents (Guerra et al. 1998; Koza et al. 2000; Coulter et al. 2003; Xue et al. 2005 Xue et al. , 2007 . These experiments were carried out using AXB recombinant inbred (RI) strains of mice derived from the B6 and A/J parent strains. The ''browning'' responses to b3-adrengergic receptor agonists in white adipose depots, and the retroperitoneal fat in particular, varied significantly among these RI strains. Quantitative trait locus (QTL) analyses showed that certain genetic variations have a significant impact on UCP1 induction in white fat, whereas they have a minimal effect on the interscapular brown fat. While no genes have yet been identified here, this has theoretically offered an experimental approach toward identifying regulators of this biological process. This also suggests that this process might be under genetic control in larger mammals, such as humans.
Two types of thermogenic adipocytes
Gene expression profiling experiments had previously shown that classical brown fat cells from the interscapular region expressed certain genes typically found in skeletal muscle cells (Timmons et al. 2007 ). Direct evidence illustrating a developmental link between brown fat and skeletal muscle and that there were two different types of thermogenic fat cells came in Seale et al. (2008) . To establish the requirement for PRDM16 in brown adipocytes, Seale et al. (2008) knocked down PRDM16 expression with an shRNA in primary brown fat cultures and found that typical skeletal muscle genes were induced in these cells. Moreover, these cells took on a dramatic, myotube-like morphology, showing periodic twitching in the cell culture dish. Lineage tracing experiments in vivo, marking myogenic factor 5 (Myf5)-expressing progenitors, were performed to establish the developmental origin of the classical brown fat cells. Myf5 has been previously thought to only be expressed in committed precursors that give rise to skeletal muscle. These experiments showed that brown fat cells in the interscapular and perirenal depots originate from the same or similar progenitors as skeletal muscle. In contrast, the UCP1 + fat cells that arise in classical white adipose depots under prolonged b-adrenergic stimulation definitely come from a non-Myf5-derived cell lineage.
The common origin of brown fat and skeletal muscle was further confirmed and refined in a lineage tracing experiment (Lepper and Fan 2010) using timed activation of a marker gene driven by Pax7. The time point at which precursors between skeletal muscle and brown fat diverge was pinpointed between embryonic day 9.5 (E9.5) and E11.5. A more recent study confirmed that classical brown fat (interscapular and perirenal) comes from a Myf5 + lineage but also suggested that at least some adipocytes from a broader range of fat depots may arise from the Myf5 lineage (Sanchez-Gurmaches et al. 2012) . Importantly, all of these data illustrate that the ''brown'' fat cells emerging in white depots are from a completely different cell lineage than classical brown fat cells (Fig. 1 ).
Identification and isolation of beige adipocytes
While classical brown fat cells have been isolated, immortalized, and studied for many years, beige fat cells had, until recently, never been isolated or cloned. In fact, it had been suggested that the ''brown conversion'' of white fat could be an inherent property of most or all white fat cells and that this ''transdifferentiation'' may not be due to the presence of a distinct cell type with this predisposition (Himms-Hagen et al. 2000; Cinti 2002 ). While the potential for this kind of transdifferentiation has not been definitively disproven, several lines of direct evidence in support of the existence of beige precursors in white depots have been published in recent years.
Beige clonal cell lines and the isolation of beige precursors To circumvent the ambiguities inherent in the interpretation of data from studies of heterogeneous primary cell cultures and adipose tissues in vivo, we subcloned multiple preadipose cell lines from immortalized stromal cultures derived from either the subcutaneous white fat or the interscapular brown fat of mice . Clustering analysis of gene expression patterns suggested that a subgroup of the subcutaneous (inguinal depot) lines had a gene expression pattern more similar to the classical brown fat cell lines than to the other inguinal cell lines. This strongly suggested that a distinct type of precursor cell could give rise to beige fat cells, and these clonal cell lines offered a ''pure'' system to investigate the molecular signature and distinct functions of this new type of fat cell. Beige fat cells have a very low basal level of UCP1 (roughly equivalent to the immortalized white cells from the same mice) but can robustly respond to cAMP to activate a thermogenic program to levels similar to those seen in the brown cell lines from the classical interscapular depot (Fig. 2) . Perhaps most importantly, this study illustrated that the UCP1 + cells detected in the supraclavicular region of healthy human adults have a molecular phenotype that is much more similar to murine beige fat cells rather than brown fat cells (see detailed discussions in ''Human Brown and Beige Fat'' below).
Brown in white (brite) cells The effects of thiazolidinediones (TZDs) and other PPARg agonists on mitochondrial biogenesis and respiration in WATs have been well documented (Fukui et al. 2000; Laplante et al. 2003; Wilson-Fritch et al. 2003 Vernochet et al. 2009 ). Many hypotheses have been proposed to explain this phenomenon. It remains unknown whether TZDs' effects on mitochondrial biogenesis and adaptive thermogenesis Figure 1 . Origins of fat cells. At least three types of precursors give rise to white, beige, and brown adipose cells separately. Precursors for brown adipocytes developmentally originate from dermomyotome and express Pax7 and Myf5. White and beige adipocytes come from two distinct populations of precursors of Pax7-and Myf5-negative lineages. While PPARg is essential for adipogenesis of all fat cells, various transcriptional components play different roles in the development, commitment, and differentiation of white, beige, and brown fat, and PRDM16 has been shown to play an important role in regulating both brown and beige fat (for details, see the text).
contribute directly to the improvement of systemic insulin sensitivity in vivo.
Chronic treatment of primary precursors from the visceral WAT depot (epididymal) with PPARg agonists showed that only a subpopulation of these precursors can attain a ''brown''-like phenotype (Petrovic et al. 2010 ). The expression levels of previously described markers for different adipose depots were investigated (Gesta et al. 2006) . In a follow-up study, the various responses to stimulation of the adipocytes in different depots were further investigated (Walden et al. 2012) . From these studies, the investigators proposed the existence of a subtype of precursor that gives rise to UCP1 + adipocytes in white adipose depots and named these cells ''brite'' fat. Although further experimental evidence is needed, it is tempting to hypothesize that beige and brite cells are the same type of cells in vivo.
The mechanism by which PPARg agonists induce brown remodeling appears to involve post-translational modification of PPARg. Agonist treatment was shown to lead to deacetylation of PPARg, which is dependent on the NADdependent deacetylase SirT1 (Qiang et al. 2012) . Either gain of function of SirT1 or loss of function of its inhibitor, Dbc1, results in deacetylation of PPARg and induction of thermogenic gene expression. This process is mediated by increased recruitment of PRDM16 to deacetylated PPARg.
Adipose tissue stem cells (ASCs) with thermogenic potential Even though the definition of ASCs is still presently being debated among experts in the field, a significant amount of knowledge on adipocyte biology has been generated from related studies. The recent progress in this area has been reviewed elsewhere (Cawthorn et al. 2012) , so this review only discusses the studies that focus on ASCs with thermogenic potential.
Subpopulations of adipose progenitors have been isolated using different combinations of cell surface markers from enzyme-digested adipose tissue and skeletal muscle (Rodeheffer et al. 2008; Joe et al. 2010; Uezumi et al. 2010) . The cell surface markers in these studies were largely selected based on expression levels in stem cell populations derived from other tissues, including CD31 (an endothelial marker), CD45 (a pan-hematopoietic marker), and SM/C-2.6 (a satellite cell marker; precursor for myotubes), among others. The identity of each subpopulation from fluorescence-activated cell sorting (FACS) was tested empirically with functional assays for adipogenesis and adaptive thermogenesis. Friedman's group (Rodeheffer et al. 2008) :SM/C-2.6 À :PDGFRa + ) were also isolated from skeletal muscle (Uezumi et al. 2010) . However, whether these populations respond to stimulation and activate a thermogenic program was not tested in either study. Another subpopulation (Sca-1 + : CD45 À :Mac1 À , referred to as ScaPCs) can be isolated from fractioned interscapular brown fat, subcutaneous white fat, and skeletal muscle and can attain brown-like phenotypes when treated with bone morphogenetic protein 7 (BMP7) (for more on BMPs, see ''Secreted Molecules That Activate BAT and/or Induce Beiging in WAT'' below) (Schulz et al. 2011) . A bipotential adipogenic subpopulation (PDGFRa + :Sca-1 + :CD34 + ; so-called PDGFRa + cells) has recently been proposed . Upon b-adrenergic stimulation, there is a significant proliferation of PDGFRa + in epididymal (visceral) WAT in mice, whereas in high-fat diet-challenged mice, the PDGFRa + cells gave rise to unilocular white fat cells. Since these subpopulations from primary ASC cultures are themselves heterogeneous, the molecular identity of these precursors (being brown, beige, or something else, for example) remains elusive.
Multiple genetic models have shown modified adaptive thermogenesis capacity in brown/beige fat
The number of studies that describe genetic models with an altered development and/or function of brown and beige fat has been increasing at a remarkable rate in recent years. Due to space limitations, we are not able to discuss all of these studies here, but we highlight a few representative reports. A more comprehensive list is summarized in Table 2 .
Cyclooxygenase-2 (Cox2)
COX-2 is a rate-limiting enzyme in prostaglandin (PG) synthesis and has recently been shown to play a role in regulating the recruitment and activation of beige fat cells in mice (Vegiopoulos et al. 2010) . The expression level of COX-2 is induced upon sympathetic stimulation in both subcutaneous and intra-abdominal white fat tissues. In a mouse model with ectopic expression of COX-2 in the skin, adaptive thermogenic genes are induced in WAT but not interscapular BAT. Conversely, loss or inhibition of COX-2 activity in vivo leads to a blunted response to b3-adrenergic stimulation in WAT (+) The factor affects the thermogenic adipocytes in that depot; (À) no effects; (;) the potential regulation has not yet been investigated. For factors identified and characterized in heterogenous systems (for example, mouse embryonic fibroblasts), their specific contributions to different fat cell types await further studies. The effects of each factor on different fat depots in genetic-mutated rodent models may be caused by either direct regulation of adipocytes within that depot or systematic changes of overall adiposity.
but not BAT. As a result of its regulatory role in ''beiging,'' excess activity of COX-2 in vivo is sufficient to protect the transgenic mice from weight gain and associated hyperglycemia from a high-fat diet. Further studies are warranted to reveal the molecular mechanism by which local PG production can influence browning/beiging and systematic energy expenditure. The intriguing observation that COX-2 induces/activates UCP1 + cells in both subcutaneous and visceral WAT is consistent with the hypothesis that beige adipocytes/beige precursors exist in multiple WAT depots.
FoxC2
FoxC2 is a forkhead/winged helix transcription factor family member that regulates brown fat development. Transgenic expression of FoxC2 in WAT results in a brown fat phenotype with increased mitochondrial content and thermogenic gene expression (Cederberg et al. 2001; Kim et al. 2005) . These transgenic mice are also insulinsensitive and resistant to dietary obesity. This effect is mediated by increased sensitization to the b-adrenergic receptor-cAMP-PKA pathway and seems to be due to direct induction of the RIa subunit of PKA by FoxC2 (Cederberg et al. 2001; Dahle et al. 2002) . It remains unknown whether FoxC2 is genetically required for the brown fat phenotype.
IKKe
It has been shown that a high-fat diet activates NF-kB in the adipose tissue and the liver. Deletion of IkB kinase e (IKKe), a direct downstream target of the NF-kB pathway, increases energy expenditure and protects IKKe knockout mice from diet-induced obesity (Chiang et al. 2009 ). UCP1 expression is induced in the visceral fat (epididymal WAT) but remains similar to controls in the interscapular brown fat. The change in the WAT is consistent with an increased body temperature and oxygen consumption rate. The subcutaneous WAT was not investigated in this study. Future work on the development and function of beige fat in this model may provide insights for molecular mechanisms.
PGC-1a
PGC-1a is a key nodal point in the thermogenic pathway. Broadly speaking, factors regulate this program either via direct action on PGC-1a or, secondarily, by regulating cAMP-dependent gene expression. Both the retinoblastoma protein (pRb) and the Rb family member p107 repress PGC-1a. Deletion of either factor in adipocyte precursors promotes a brown fat phenotype with increased expression of UCP1 and PGC-1a (Hansen et al. 2004; Scime et al. 2005) . The in vivo requirement for pRb in brown fat development has been uncertain, since pRb knockout is embryonic-lethal (Clarke et al. 1992; Jacks et al. 1992; Lee et al. 1992) . A more recent study, however, addressed this question by deleting p53 and pRb specifically in mesenchymal cells. Prx1-Cre;p53 flox/flox mice tended to develop osteosarcomas, whereas deletion of both p53 and pRb in mesenchymal cells resulted in the preferential formation of brown adipose-containing tumors called hibernomas (Calo et al. 2010 ). These in vivo findings indicate that pRb may modulate a cell fate choice between bone and brown adipose. The requirements of PGC-1a itself in brown and beige fat development and function have been studied in mice with fatspecific deletion of PGC-1a ). The expression of thermogenic genes at ambient temperature is reduced in both subcutaneous and visceral white fat in the absence of PGC-1a, whereas brown fat function largely remains intact, possibly due to compensation from other brown-selective regulators .
PRDM16
PRDM16 plays a pivotal role in regulating brown fat cell fate and function [for details, see ''Brown Adipose Tissue (BAT)'' above]. The potential role of this molecule in modulating beige fat cell function was investigated in the fat-specific PRDM16 transgenic mouse model (Seale et al. 2011) . Ectopic expression of PRDM16 in the adipocytes showed little effects in classical brown fat, possibly due to the relatively high basal expression in this depot. The thermogenic program is greatly induced in the subcutaneous white fat depots, but not the visceral, in the PRDM16 fat transgenic mice compared with the controls (Seale et al. 2011) . A depot-dependent discrepancy between PRDM16 mRNA and protein levels was noted, likely caused by differential stability of PRDM16 in subcutaneous and visceral white adipose .
The increased abundance of UCP1 + cells within the subcutaneous adipose protects PRDM16 fat transgenic mice against diet-induced obesity and significantly improves glucose tolerance (Seale et al. 2011) . The therapeutic potential of PRDM16 can be explored by multiple approaches. ''Engineered'' brown fat cells with ectopic expression of both PRDM16 and C/EBPb can actively uptake glucose in vivo after subcutaneous transplantation in rodents (Kajimura et al. 2009) . It has been shown that PRDM16 expression can be regulated by microRNAs (Sun et al. 2011; Trajkovski et al. 2012) . When treated with hemopoietin cocktail, PRDM16 is induced in human pluripotent stem cells (hPSCs), and these hPSCderived brown adipocytes showed thermogenic activation by adrenergic stimulation (Nishio et al. 2012 ).
RIP140
The nuclear receptor corepressor RIP140 also regulates brown adipose development and function. RIP140 directly binds to PGC-1a and antagonizes its transactivation of thermogenic target genes (Hallberg et al. 2008) . Overexpression of RIP140 in adipocytes represses expression of genes involved in mitochondrial biogenesis and oxidative metabolism (Leonardsson et al. 2004; Christian et al. 2005; Powelka et al. 2006) . Conversely, deletion of RIP140 results in the appearance of brown-like adipocytes within WAT (Leonardsson et al. 2004 ).
Steroid receptor coactivator (SRC)
The SRC family members also play a role in thermogenesis (Louet and O'Malley 2007) . SRC-1/NcoA1 knockout mice have impaired adaptive thermogenesis, while SRC-2/TIF2 knockout mice demonstrate enhanced adaptive thermogenesis (Picard et al. 2002) . The mechanism appears to be via effects on PGC-1a, as SRC-1 enhances coactivation of PPARg by PGC-1a, whereas SRC-2 inhibits PPARg-PGC-1a interaction. SRC-3/pCip deletion results in increased mitochondrial content and brown adipose with anti-obesity and insulin-sensitizing effects (Louet et al. 2006; Coste et al. 2008) . This too appears to be via effects on PGC-1a, as SRC-3 induces GCN5, which acetylates and inhibits PGC-1a (Lerin et al. 2006 ).
Transient receptor potential vanilloid 4 (TRPV4)
The TRPV receptors are a family of ion channels. A chemical screen for small molecules that induce PGC-1a expression in adipocytes revealed that TRPV4 negatively regulates the expression of PGC-1a, UCP1, and cellular respiration ). In the same study, the investigators also uncovered that TRPV4 controls a program of proinflammatory genes that contributes to the development of insulin resistance. This dual role of TRPV4 in regulating the metabolic functions of adipocytes makes it a compelling target for drug development. In fact, mice treated with a TRPV4 antagonist showed elevated thermogenesis and were protected from diet-induced obesity, adipose inflammation, and insulin resistance.
Secreted molecules that activate BAT and/or induce beiging in WAT
Signaling molecules represent a straightforward link between basic research and clinical applications. A spectrum of these molecules has been reported to play a role in regulating brown or beige fat function in vivo (see Table 3 ).
Cardiac natriuretic peptides (NPs)
The NP family is comprised of atrial NP (ANP), brain NP (BNP, first identified in the porcine brain), and C-type NP (NP). ANP and BNP are predominantly released from the atria and ventricles, respectively, and are therefore called cardiac NPs. These peptides regulate natriuresis, body water, and ion homeostasis. The potential role of cardiac NPs in fat was suggested by the expression of NP receptors in adipose tissues (Sarzani et al. 1993 (Sarzani et al. , 1996 and later observations that NPs regulate lipolysis in adipose tissue, especially during exercise (Sengenes et al. 2000; Moro et al. 2004 Moro et al. , 2006 . A recent study showed that thermogenic programs are induced in ANP-treated human primary adipocytes in vitro. Moreover, BNP infusion in mice induces UCP1 expression in both BAT and inguinal subcutaneous WAT and increases system energy expenditure (Bordicchia et al. 2012) . The browning/beiging effects of cardiac NPs are also supported by the analysis of mice with deletion of the NP clearance receptor (Nprc).
NP receptor A (NPRA) mediates the signals from ANP and BNP and generates the second messenger, cGMP, whereas the NPRC removes NPs from circulation. UCP1 is induced in all adipose tissues in the Nprc À/À mice compared with controls, and, furthermore, the ratio of NPRA/NPRC is increased in wild-type mice upon cold exposure. The detailed mechanism of how NPs regulate thermogenic programs remains unknown, but the p38/ MAPK pathway may be involved.
Fibroblast growth factor 21 (FGF21)
FGF21 is an endocrine hormone that belongs to the FGF family and has been shown to play an important role in regulating the fasting response in the liver (Kharitonenkov et al. 2005; Badman et al. 2007; Inagaki et al. 2007 ). More recently, FGF21 has been shown to play a role in adaptive thermogenesis in both BATs and WATs (Hondares et al. 2010; Fisher et al. 2012) . FGF21 is secreted locally by adipose tissues under certain conditions such as cold, and this polypeptide regulates browning/beiging, at least in part, through stimulating accumulation of PGC-1a protein (Fisher et al. 2012) . The therapeutic potential of FGF21 is hindered by the fact that systematic administration of FGF21 promotes bone loss, possibly through PPARg (Wei et al. 2012 ). However, local induction/ administration of FGF21 without increasing FGF21 in circulation remains an attractive avenue for therapeutics. Other members of the FGF family have also been reported to be involved in regulating energy expenditure in rodents (Konishi et al. 2000; Fu et al. 2004; Jonker et al. 2012) .
Fibronectin type III domain-containing 5 (FNDC5)/irisin
It has been observed that resting metabolic rate (RMR) is increased over a prolonged period of time with both acute and long-term exercise training, and these effects have been believed to be mediated by increased lean tissue mass (Speakman and Selman 2003) . Not until recently was it suggested that the beneficial effects of exercise may also come from changes in energy expenditure in both BAT and WAT . PGC-1a is induced during exercise (Pilegaard et al. 2003; Russell et al. 2003) and regulates many exercise-related pathways in skeletal muscle (Lin et al. 2002; Sandri et al. 2006; Handschin et al. 2007; Wu et al. 2011) . Muscle-specific ectopic expression of PGC-1a increases whole-body energy expenditure and protects mice from age-related obesity (Wenz et al. 2009 ). Consistent with the hypothesis that the signal is transduced from skeletal muscle to adipose tissues in exercise, the subcutaneous WAT in musclespecific PGC-1a transgenic mice shows elevated expression of UCP1. Global gene expression profiling was done to compare muscles of mice with elevated expression of PGC-1a and wild-type controls. FNDC5 (also known as FRCP2 and PeP) was then predicted to be a secreted protein that was expressed at a higher level in skeletal muscle post-exercise or with ectopic PGC-1a expression Lecker et al. 2012 ). In vitro treatment of primary adipocytes with FNDC5 protein or adenoviral delivery of FNDC5 in vivo to the liver induces thermogenic gene expression, including UCP1 and Cidea, in the adipose cells/tissues. A cleaved form of FNDC5, named irisin, can be detected in both human and murine sera samples with increased amounts following exercise Huh et al. 2012) . It was later shown that beige fat preferentially responds to this polypeptide hormone, but the molecular mechanisms by which irisin activates beige fat remain elusive . Whether this new hormone contributes to the beneficial effects of exercise in other tissues and organs awaits further studies.
Retinaldehyde dehydrogenase (Raldh)
Raldh1 (also known as Aldh1a1) is the rate-limiting enzyme that converts retinaldehyde (Rald) to retinoic acid. Deletion of Raldh in mice results in increased Rald levels and protection from dietary obesity and diabetes, as a consequence of increased energy expenditure (Ziouzenkova et al. 2007 ). In a follow-up study, Raldh was found to be enriched in visceral adipose tissue, and deficiency of this enzyme resulted in a brown fat-like phenotype in visceral white fat (Kiefer et al. 2012 ). This appears to be mediated by increased Rald levels, resulting in activation of the retinoic acid receptor, recruitment of PGC-1a, and increased UCP1 expression.
Transforming growth factor-b (TGF-b) and BMPs
The role of the TGF-b signaling pathway and proteins in the BMP families in adipocyte biology has been an exciting area (Jin et al. 2006; Zamani and Brown 2011; Yadav and Rane 2012) . TGF-b and its related proteins play an important role in regulating growth, development, and cell fate commitment in many cell types (Chen et al. 2004; Mullen et al. 2011) . It has been observed that TGF-b levels correlate with adiposity in both mice and humans (Samad et al. 1997; Alessi et al. 2000; Fain et al. 2005) . Smad3 À/À mice have increased mitochondrial biogenesis in the WATs and are protected from diet-induced obesity and diabetes (Yadav et al. 2011) . Mesenchymal progenitor cells are committed to a brown cell fate upon BMP7 treatment, and adenoviral overexpression of BMP7 in mice increases energy expenditure and protects against dietinduced weight gain (Tseng et al. 2008 ). BMP8B, a brown fat-enriched BMP, has recently been shown to activate thermogenesis in rodents (Whittle et al. 2012) . BMP8B treatment potentiates brown adipocytes' response to norepinephrine and also acts on hypothalamus and alters central control of sympathetic activation of BAT. BMP8B-null mice show decreased energy expenditure and gain more body weight despite reduced food intake (Whittle et al. 2012) . Another example of the role of TGFb signaling was demonstrated via administration of soluble activin receptor type IIB (ActRIIB) in mice. A recombinant protein of the extracellular domain of ActRIIB and the Fc fraction of human IgG was given to mice and led to increased expression of UCP1 and PGC-1a in WAT and protection against diet-induced obesity (Koncarevic et al. 2012) .
Human brown and beige fat
Several recent reviews have summarized studies of UCP1-positive cells in humans (Enerback 2010a; van Marken Lichtenbelt and Schrauwen 2011) . Rediscovery of ''thermogenic'' UCP1-positive adipocytes in adult humans (Cypess et al. 2009; van Marken Lichtenbelt et al. 2009; Virtanen et al. 2009; Zingaretti et al. 2009 ) has presented a unique opportunity to counter obesity in humans. A growing body of data demonstrated that adaptive thermogenesis may play a rather significant role in human physiology.
The brown-selective and beige-selective markers identified from murine clonal cell lines provided a powerful tool to investigate the molecular identity of UCP1 + cells in human adults ). Analyses of supraclavicular biopsies from two cohorts of healthy human adults reveal that beige markers are significantly enriched in the UCP1 + , so-called ''BAT'' samples in comparison with the neighboring ''white'' fat controls. Meanwhile, the expression level of brown-selective markers is comparable between UCP1 + and UCP1 À biopsy samples. This strongly suggests that these metabolically active cells are molecularly similar to murine beige adipocytes. This observation has been confirmed by two recent reports (Sharp et al. 2012; Lidell et al. 2013) . Gene expression analyses of autopsy samples of multiple human fat depots suggest that the majority of UCP1
+ fat cells in humans show beige fat characteristics instead of brown (Sharp et al. 2012) . Studies of fat tissues from the interscapular region of human infants post-mortem confirmed that this depot in human infants is composed of classical brown adipocytes just like smaller mammals (Lidell et al. 2013) . Most of the studies on human ''brown'' fat reported so far were actually done with the UCP1 + beige fat cells in the supraclavicular region of human adults. To avoid confusion, in this review, we refer to those cells as human brown/beige fat.
Technical advances in detecting human brown/beige fat
The existence of brown fat within the interscapular depot of human newborns and in adults with pheochromocytoma is well documented (Aherne and Hull 1966; Heaton 1972; Ricquier et al. 1982; Lean et al. 1986a,b) . The recent rediscoveries of human ''brown'' fat were made possible by so-called metabolic imaging techniques, which involve the combination of 18-fluoro-deoxy-glucose ( 18 F-FDG), PET, and computed tomography (CT). The sensitivity of this technique is limited, and it only measures brown/beige fat activity by means of radioactive [
18 F]FDG uptake. It is highly likely that fatty acids in the plasma compete with glucose for cellular uptake, especially when adaptive thermogenesis is activated and there is an increased fuel demand. Therefore, PET/CT will underestimate true brown/beige fat activity in vivo.
Several alternative approaches have been proposed to locate, characterize, and quantitate brown/beige fat in vivo. One approach is to use blood oxygen level-dependent magnetic resonance imaging (BOLD MRI) to monitor the increase in oxygen consumption and consequent increase in blood deoxyhemoglobin levels following BAT activation (Khanna and Branca 2012) . Another approach was designed based on the fact that activation of brown/beige fat is accompanied by mitochondrial thermogenesis. The retention of 18 F-FBnTP (a mitochondria-targeting voltage sensor-radiolabeled fluorobenzyltriphenyl phosphonium) was assayed as an indicator of brown/beige fat volume and function (Madar et al. 2011) . A recent study describes contrast ultrasound (CU) as a novel noninvasive approach to monitor and characterize the activation of BAT in rodents based on the change of blood flow into the tissue (Baron et al. 2012) . It is reasonable to anticipate that other noninvasive, convenient, and sensitive measures will be developed as a better understanding of brown and beige fat biology is achieved.
Metabolic functions of human brown/beige fat and its correlation with metabolic profiles
In the past 4 years, many new reports revealed correlations between brown/beige fat function and metabolic homeostasis in humans. First of all, it has been noticed that there is more active brown/beige fat in women than in men (Au-Yong et al. 2009; Cypess et al. 2009; Lee et al. 2010; Pfannenberg et al. 2010) . The sexual dimorphism in brown/beige fat activity is also reported in rodents (Rodriguez-Cuenca et al. 2002) . While the molecular mechanism is still under investigation, the gender differences and the hormonal environment should definitely be taken into consideration for any potential therapeutic modulation of brown/beige fat activity in humans. However, it is worth noting that serum testosterone levels inversely correlate with abdominal obesity in men, and androgen receptor-null male mice develop late-onset obesity, possibly due to reduced expression of UCP1 (Yanase et al. 2008) . The detected brown/beige fat activity correlates inversely with the age of tested subjects (Ouellet et al. 2011) , is rather low in obese subjects, and is increased after weight loss from bariatric surgery (Vijgen et al. 2011 (Vijgen et al. , 2012 ). An interesting observation is that unlike what has been observed in rodents, systemic administration of a sympathomimetic substance does not induce detectable activity in human brown/beige fat (Cypess et al. 2012; Vosselman et al. 2012) . Since the doses in these studies are comparable with the physiological level of sympathetic tone induced by mild cold exposure, where brown/beige fat activity is activated, a definitive explanation for this discrepancy remains elusive. Regardless of the molecular mechanism for this phenomenon, serious side effects associated with higher doses of sympathomimetic substance preclude this approach from direct clinical use. The causal or even clear correlative relationship between brown/beige fat function and overall metabolic fitness in humans awaits a better understanding of the basic biology of these thermogenic cells and improved analyzing tools to detect and quantitate brown/beige fat in humans.
Open questions and future directions
The explosive progress in brown fat has opened up many exciting prospects for the future in both basic science and therapeutics. We now know that there are two types of distinct thermogenic adipose cells: brown and beige. However, it is entirely possible that there are yet more important thermogenic cell types to be discovered. For example, it is known that the ''brown'' cells that develop in visceral fat are not classical Myf5 lineage-derived cells, but it is not yet clear whether these are beige cells or yet another distinct cell type. Another important question relates to the neural connections of the nonclassical brown fat cells, beige or other. We know that all of these cells, brown and beige, are sensitive to cold-induced signals from the sympathetic nervous system and b-adrenergic signaling. However, we do not have a clear view of what other neural pathways might innervate these nonclassical beige fat cells and bring about a thermogenic response. A thorough characterization of the innervation of these cells is warranted.
Another gap in our knowledge relates to the transcriptional basis for the development of both brown and beige fat cells. PRDM16 is certainly a major contributor to the development of both of these cells, but PRDM16 is expressed in brown and beige cells and does not appear to be the factor that distinguishes them. Since the DNAbinding activity of PRDM16 is not required for its browning effects, it is almost certainly acting as a transcriptional coregulator , docking on distinct DNA-binding transcription factors to drive the expression of distinct pathways. In some cases, such as nuclear receptors, the transcription factors themselves can offer opportunities for modulation of function in vivo.
That brown fat (in all of its forms) can modulate obesity and diabetes in experimental models must now be considered settled science. Ablation of brown fat with a toxigene driven by the UCP1 promoter or a knockout of the UCP1 gene both give mice an increased level of obesity and diabetes (Lowell et al. 1993; Feldmann et al. 2009 ). However, it should be noted that this results in defective function of both brown and beige fat and does not distinguish between the contributions of either individually. Many gain-of-function models also show a resistance to weight gain on a high-fat diet and resistance to type 2 diabetes. These include modulation of transcriptional components like FoxC2 and PRDM16, direct regulators of cAMP and cGMP signaling, and various members and regulators of the TGFb family (see ''Multiple Genetic Models Have Shown Modified Adaptive Thermogenesis Capacity in Brown/Beige Fat'' and ''Secreted Molecules That Activate BAT and/or Induce Beiging in WAT'' above). However, again, either most of these studies do not distinguish between activation of classical brown and beige fat or these pathways work on both. One exception was the forced expression of PRDM16 in adipose tissues, which causes browning of the white fat and increased UCP1 expression but has no discernable effect on the classical brown fat (Seale et al. 2011) . This model establishes that expansion of beige fat (and its function) can have an effect on fat accretion and glucose homeostasis.
Which of the two types of thermogenic fat would be best to target for treating obesity and diabetes in adult humans? It is now clear that human brown fat is actually composed of beige fat cells, so increasing the amount and thermogenic capacity of these cells might be more obviously accessible. While this is a relatively recently understood target, it is already clear that beige fat cells are a distinct cell type and that there is already one polypeptide hormone that preferentially activates beige fat: irisin. Since it is also clear that there are cell surface proteins that are expressed selectively on beige cells , it is very likely that there will be other natural or synthetic molecules that can elicit a useful response from beige fat cells. On the other hand, humans do have classical brown fat, at least as infants, and it is possible that these cells can be developed again and reactivated under certain conditions. Still, targeting beige fat might be somewhat simpler, at least at this early stage of our knowledge.
Because brown fat cells of all types can dissipate stored chemical energy as heat, the most obvious therapeutic application is in the treatment of obesity. Although preliminary calculations suggest that adult humans have enough brown or beige fat to make a difference in body weight if fully activated (Enerback 2010b) , there are so many unknowns regarding amounts and activity states of brown fat in most humans that such calculations must be considered very approximate. It is also worth noting that activation of brown or beige fat has a powerful antidiabetic effect that might go beyond effects on obesity per se. This was apparent with transgenic expression of PRDM16, which caused browning of subcutaneous fat and a modest effect on body weight but a profound improvement in glucose tolerance. Whether this was due to preferential removal of glucose from blood by beige fat or secretion of an anti-diabetic beige adipokine remains to be determined. Certainly, the next decade will see massive efforts to use beige and brown fat to ameliorate human metabolic disease.
